The nucleoside analog 4'-fluorouridine suppresses the replication of multiple enteroviruses by targeting 3D polymerase

Human enteroviruses are the major pathogens causing hand-foot-and-mouth disease in infants and young children throughout the world, and Infection with Enterovirus is also associated with severe complications, such as aseptic meningitis and myocarditis. However, there are no Antiviral drugs available to treat enteroviruses Infection at present. In this study, we found that 4'-fluorouridine (4'-FlU), a nucleoside analog with low cytotoxicity, exhibited broad-spectrum activity against infections of multiple enteroviruses with EC50 values at low micromolar levels, including coxsackievirus A10 (CV-A10), CV-A16, CV-A6, CV-A7, CV-B3, Enterovirus A71 (EV-A71), EV-A89, EV-D68, and echovirus 6. With further investigation, the results indicated that 4'-FlU directly interacted with the RNA-dependent RNA polymerase of Enterovirus, the 3D ^pol, and impaired the polymerase activity of 3D ^pol, hence inhibiting viral RNA synthesis and significantly suppressing viral replication. Our findings suggest that 4'-FlU could be promisingly developed as a broad-spectrum direct-acting Antiviral agent for anti-enteroviruses therapy.

3D polymerase; 4′-fluorouridine; RdRp; antiviral agents; coxsackievirus; enterovirus.